Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v3.24.1.u1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenue:    
Total revenue $ 7,639 $ 5,433
Cost of revenue 3,114 2,231
Gross profit 4,525 3,202
Research and development costs 2,625 3,023
Sales and marketing expenses 3,290 2,933
General and administrative expenses 2,841 2,958
Operating loss (4,231) (5,712)
Other expense:    
Other expense, net (26) (11)
Interest income, net 111 114
Net loss $ (4,146) $ (5,609)
Net loss per share attributable to common stockholders:    
Basic (in dollars per share) $ (0.16) $ (0.23)
Diluted (in dollars per share) $ (0.16) $ (0.23)
Weighted average shares used in computing net loss per share:    
Basic (in shares) 25,452,096 24,583,163
Diluted (in shares) 25,452,096 24,583,163
Product revenue    
Revenue:    
Total revenue $ 3,635 $ 2,630
Service and other revenue    
Revenue:    
Total revenue $ 4,004 $ 2,803